Next Article in Journal
Immunogenicity and Antibody Persistence of the Inactivated Quadrivalent Influenza Vaccine in Pediatric Patients Post-Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation Versus Healthy Controls
Previous Article in Journal
The Influence of Health Education on Vaccination Coverage and Knowledge of the School Population Related to Vaccination and Infection Caused by the Human Papillomavirus
Previous Article in Special Issue
Confronting Inequalities and Bridging the Divide: A Retrospective Study Assessment of Country-Level COVID-19 Vaccine Equality with a Cox Regression Model
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 12
Issue 11
10.3390/vaccines12111223
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Special Issue: “Vaccination and Global Health”

by
Shaodi Ma
1,†,
Qian Bi
2,†,
Li Liu
3,4,
Roshan Thapa
5,
Wenle Li
6,
Baocheng Liu
7,
Chuanhui Xu
8,9 and
Chenyu Sun
10,11,*
1
Anhui Provincial Center for Disease Control and Prevention, Public Health Research Institute of Anhui Province, Hefei 230601, China
2
Department of Radiation Oncology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
3
The Second People’s Hospital of Hefei, Guangde Road, Hefei 230011, China
4
Hefei Hospital Affiliated to Anhui Medical University, Guangde Road, Hefei 230011, China
5
General Internal Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
6
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen 361005, China
7
Shanghai Innovation Center of Traditional Chinese Medicine Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
8
Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore 308433, Singapore
9
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 545000, Singapore
10
Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Furong Road 678, Hefei 230601, China
11
International Medical Department, The Second Affiliated Hospital of Anhui Medical University, Furong Road 678, Hefei 230601, China
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Vaccines 2024, 12(11), 1223; https://doi.org/10.3390/vaccines12111223
Submission received: 11 October 2024 / Accepted: 22 October 2024 / Published: 28 October 2024
(This article belongs to the Special Issue Vaccination and Global Health)
Versions Notes

1. Introduction

This Special Issue, titled ‘Vaccination and Global Health,’ compiles 11 broad-ranging papers, each exploring critical facets of vaccination, public health, and global healthcare systems [1,2,3,4,5,6,7,8,9,10,11]. These contributions add to the expanding body of research aimed at tackling the numerous challenges related to vaccination on a global scale. This Special Issue highlights the timeliness and significance of these contributions to the field. In this editorial, we provide a concise overview of the key findings from each paper, address the knowledge gaps filled by this Special Issue, and propose future research directions in this continuously evolving field.

2. Overview of Published Papers

The articles featured in this Special Issue cover a broad spectrum of topics, ranging from the development of novel vaccine technologies to the evaluation of vaccine efficacy across diverse populations. Several papers focus on the public health implications of vaccination programs, offering valuable insights into vaccine coverage, hesitancy, and the efficacy of global immunization efforts [3,4,5]. In one of the studies, Contoli et al. explores the willingness of foreign residents in Italy to be vaccinated, revealing the challenges faced by immigrant populations in terms of vaccine uptake. Their findings suggest the need for targeted communication strategies to increase vaccination rates in different communities [2]. Other articles examine the barriers to vaccine access in resource-limited settings and propose strategies to enhance global vaccine distribution [1,6]. Moreover, researchers also provide evidence for delivering vaccines as part of a humanitarian response by conducting a systematic review, which has contributed to the mapping of the normative landscape of vaccination guidance for vaccine-preventable diseases in crisis-affected settings [10].
A notable contribution is a study evaluating the implementation of COVID-19 vaccination programs in low- and middle-income countries [8]. The authors provide compelling evidence demonstrating the success of localized strategies tailored to specific regions. Another significant paper explores vaccine hesitancy by examining the socio-cultural factors that shaped public attitudes toward vaccination during the COVID-19 pandemic [4]. In addition, Kunieda et al. investigated the factors influencing measles vaccination rates in Niger [6], and recommended an increased focus on equity-based individual factors, including personal motivation, prompts and ability to access vaccination services. These studies provide valuable information and in-depth insights for enhancing vaccine acceptance globally, particularly through targeted educational campaigns and community engagement strategies [4,6].

3. Addressing Knowledge Gaps

This Special Issue addresses several pivotal knowledge gaps within the landscape of vaccination and global health. For example, several papers emphasize the challenges associated with ensuring equitable vaccine access, particularly among marginalized populations [1,8,9]. These findings are both timely and crucial, considering the persistent need to expand vaccine coverage in underserved regions. Additionally, research on the long-term efficacy of vaccines and their effectiveness against emerging disease variants offers valuable insights that can inform future vaccination strategies [11].
These articles provide evidence-based solutions that can be adopted by policymakers and public health officials to improve global vaccine distribution and uptake [1,2,3,4,5,6,7,8,9].

4. Future Research Directions

Looking ahead, several key areas of research merit further exploration. First, there is an urgent need to investigate the long-term efficacy of existing vaccines, particularly in the context of emerging variants of concern of COVID-19 [12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27]. Future research should also focus on the development of next-generation vaccines that are adaptable to a wider range of infectious diseases and capable of offering more durable protection.
Another critical area for future investigation is the optimization of vaccination strategies in regions where vaccine access continues to be a challenge [28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66]. This includes addressing not only logistical barriers but also cultural and socio-economic factors that influence vaccine acceptance. In addition, the role of digital technologies in supporting vaccination campaigns, from tracking vaccine distribution to combating misinformation, represents a promising area that could significantly enhance global vaccination efforts [67,68,69,70,71,72,73,74,75].

5. Conclusions

The articles in this Special Issue represent valuable contributions to the fields of vaccination and global health, addressing urgent challenges and proposing innovative solutions. The insights obtained from these studies will undoubtedly shape future public health strategies and research. We extend our sincere gratitude to the authors for their outstanding contributions and to the reviewers for their diligent efforts in upholding the high standards of this journal. We hope this Special Issue continues to inspire further research and action in the vital field of global vaccination.

Author Contributions

S.M., Q.B., L.L. and C.S. gathered the relevant information, retrieved references and reviewed the literature. S.M., Q.B., C.X. and C.S. prepared the outline for the manuscript. S.M., Q.B., L.L. and C.S. wrote the manuscript. S.M., Q.B., L.L., R.T., W.L., B.L., C.X. and C.S. revised the manuscript and provided their critical opinions. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

All of the authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Cheng, L.; Chan, W.K.; Zhu, L.; Chao, M.H.; Wang, Y. Confronting Inequalities and Bridging the Divide: A Retrospective Study Assessment of Country-Level COVID-19 Vaccine Equality with a Cox Regression Model. Vaccines 2024, 12, 552. [Google Scholar] [CrossRef] [PubMed]
  2. Contoli, B.; Tosti, M.E.; Asta, F.; Minardi, V.; Marchetti, G.; Casigliani, V.; Scarso, S.; Declich, S.; Masocco, M. Exploring COVID-19 Vaccination Willingness in Italy: A Focus on Resident Foreigners and Italians Using Data from PASSI and PASSI d’Argento Surveillance Systems. Vaccines 2024, 12, 124. [Google Scholar] [CrossRef] [PubMed]
  3. Ahmad, M.; Sattar, A.; Aroosa, S.; Majeed, A.; Rasheed, M.A.; Ahmad, W.; Iqbal, A.; Omer, M.O.; Beg, B.M.; Mushtaq, R.M.Z.; et al. Attitude and Acceptance towards COVID-19 Booster Doses among Literacy Advantaged Population in Pakistan: A Cross-Sectional Study. Vaccines 2023, 11, 1238. [Google Scholar] [CrossRef] [PubMed]
  4. Daghriri, T.; Proctor, M.; Matthews, S.; Bashiri, A.H. Modeling Behavior and Vaccine Hesitancy Using Twitter-Derived US Population Sentiment during the COVID-19 Pandemic to Predict Daily Vaccination Inoculations. Vaccines 2023, 11, 709. [Google Scholar] [CrossRef]
  5. Osaghae, I.; Darkoh, C.; Chido-Amajuoyi, O.G.; Chan, W.; Padgett Wermuth, P.; Pande, M.; Cunningham, S.A.; Shete, S. Healthcare Provider’s Perceived Self-Efficacy in HPV Vaccination Hesitancy Counseling and HPV Vaccination Acceptance. Vaccines 2023, 11, 300. [Google Scholar] [CrossRef]
  6. Kunieda, M.K.; Manzo, M.L.; Subramanian, S.V.; Jimba, M. Individual- and Neighborhood-Level Factors of Measles Vaccination Coverage in Niamey, Niger: A Multilevel Analysis. Vaccines 2022, 10, 1513. [Google Scholar] [CrossRef]
  7. Yap, R.X.L.; Lai, Y.W.; Wei, C.; Ng, J.J.W.; Xu, D.; Feng, S.; Mu, R.; Thong, B.Y.; Xu, C. Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases. Vaccines 2024, 12, 274. [Google Scholar] [CrossRef]
  8. Belt, R.V.; Abdullah, S.; Mounier-Jack, S.; Sodha , S.V.; Danielson, N.; Dadari, I.; Olayinka, F.; Ray, A.; Crocker-Buque, T. Improving Equity in Urban Immunization in Low- and Middle-Income Countries: A Qualitative Document Review. Vaccines 2023, 11, 1200. [Google Scholar] [CrossRef]
  9. Ayyalasomayajula, S.; Dhawan, A.; Karattuthodi, M.S.; Thorakkattil, S.A.; Abdulsalim, S.; Elnaem, M.H.; Sridhar, S.; Unnikrishnan, M.K. A Systematic Review on Sociodemographic, Financial and Psychological Factors Associated with COVID-19 Vaccine Booster Hesitancy among Adult Population. Vaccines 2023, 11, 623. [Google Scholar] [CrossRef]
  10. Allison, L.E.; Alhaffar, M.; Checchi, F.; Abdelmagid , N.; Nor, B.; Sabahelzain, M.M.; Light, P.M.; Singh, N.S. A Systematic Review of Vaccination Guidance for Humanitarian Responses. Vaccines 2023, 11, 1743. [Google Scholar] [CrossRef]
  11. Liang, H.Y.; Wu, Y.; Yau, V.; Yin, H.X.; Lowe, S.; Bentley, R.; Ahmed, M.A.; Zhao, W.; Sun , C. SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19. Vaccines 2022, 10, 1538. [Google Scholar] [CrossRef] [PubMed]
  12. Lin, D.Y.; Zeng, D.; Gilbert, P.B. Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines. Clin. Infect. Dis. 2021, 73, 1927–1939. [Google Scholar] [CrossRef] [PubMed]
  13. Tandler, C.; Heitmann, J.S.; Michel, T.M.; Marconato, M.; Jaeger , S.U.; Tegeler, C.M.; Denk, M.; Richter, M.; Oezbek, M.T.; Maringer, Y.; et al. Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults. Int. J. Infect. Dis. 2024, 139, 69–77. [Google Scholar] [CrossRef] [PubMed]
  14. Miazga, W.; Wnuk, K.; Tatara, T.; Świtalski, J.; Matera, A.; Religioni, U.; Gujski, M. The long-term efficacy of tick-borne encephalitis vaccines available in Europe—A systematic review. BMC Infect Dis. 2023, 23, 621. [Google Scholar] [CrossRef] [PubMed]
  15. Chen, X.; Wang, W.; Chen, X.; Wu, Q.; Sun, R.; Ge, S.; Zheng, N.; Lu, W.; Yang, J.; Rodewald, L.; et al. Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint. BMC Med. 2022, 20, 36. [Google Scholar] [CrossRef]
  16. Nasreen, S.; Chung, H.; He, S.; Brown, K.A.; Gubbay, J.B.; Buchan, S.A.; Fell, D.B.; Austin, P.C.; Schwartz, K.L.; Sundaram, M.E.; et al. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat. Microbiol. 2022, 7, 379–385. [Google Scholar] [CrossRef]
  17. Pouwels, K.B.; Pritchard, E.; Matthews, P.C.; Stoesser, N.; Eyre, D.W.; Vihta, K.D.; House, T.; Hay, J.; Bell , J.I.; Newton, J.N.; et al. Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nat. Med. 2021, 27, 2127–2135. [Google Scholar] [CrossRef]
  18. Sheikh, A.; McMenamin, J.; Taylor, B.; Robertson, C.; Public Health Scotland and the EAVE II Collaborators. SARS-CoV-2 Delta VOC in Scotland: Demographics, risk of hospital admission, and vaccine effectiveness. Lancet 2021, 397, 2461–2462. [Google Scholar] [CrossRef]
  19. Reis, B.Y.; Barda, N.; Leshchinsky, M.; Kepten, E.; Hernán, M.A.; Lipsitch, M.; Dagan, N.; Balicer, R.D. Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents. N. Engl. J. Med. 2021, 385, 2101–2103. [Google Scholar] [CrossRef]
  20. Li, X.N.; Huang, Y.; Wang, W.; Jing, Q.L.; Zhang, C.H.; Qin, P.Z.; Guan, W.J.; Gan, L.; Li, Y.L.; Liu, W.H.; et al. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: A test-negative case-control real-world study. Emerg. Microbes. Infect. 2021, 10, 1751–1759. [Google Scholar] [CrossRef]
  21. McKeigue, P.M.; McAllister, D.A.; Hutchinson, S.J.; Robertson, C.; Stockton, D.; Colhoun, H.M. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): A case-control study. Lancet Respir. Med. 2022, 10, 566–572. [Google Scholar] [CrossRef] [PubMed]
  22. Ella, R.; Reddy, S.; Blackwelder, W.; Potdar, V.; Yadav, P.; Sarangi, V.; Aileni, V.K.; Kanungo, S.; Rai, S.; Reddy, P.; et al. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): Interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet 2021, 398, 2173–2184. [Google Scholar] [CrossRef] [PubMed]
  23. Barlow, R.S.; Larson, L.; Jian, K. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection during a Delta variant epidemic surge in Multnomah County, Oregon, July 2021. medRxiv 2021. [Google Scholar] [CrossRef]
  24. Tenforde, M.W.; Self, W.H.; Naioti, E.A.; Ginde, A.A.; Douin, D.J.; Olson, S.M.; Talbot, H.K.; Casey, J.D.; Mohr, N.M.; Zepeski, A.; et al. Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults—United States, March-July 2021. MMWR Morb. Mortal. Wkly. Rep. 2021, 70, 1156–1162. [Google Scholar] [CrossRef]
  25. Chia, P.Y.; Ong, S.W.X.; Chiew, C.J.; Ang, L.W.; Chavatte, J.M.; Mak, T.M.; Cui, L.; Kalimuddin, S.; Chia, W.N.; Tan, C.W.; et al. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: A multicentre cohort study. Clin. Microbiol. Infect. 2022, 28, e1–e612. [Google Scholar] [CrossRef]
  26. Keegan, L.; Truelove, S.A.; Lessler, J. Progress of the Delta variant and erosion of vaccine effectiveness, a warning from Utah. medRxiv 2021. [Google Scholar] [CrossRef]
  27. Tartof, S.Y.; Slezak, J.M.; Fischer, H.; Hong, V.; Ackerson, B.K.; Ranasinghe, O.N.; Frankland, T.B.; Ogun, O.A.; Zamparo, J.M.; Gray, S.; et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet 2021, 398, 1407–1416. [Google Scholar] [CrossRef]
  28. Pennisi, F.; Genovese, C.; Gianfredi, V. Lessons from the COVID-19 Pandemic: Promoting Vaccination and Public Health Resilience, a Narrative Review. Vaccines 2024, 12, 891. [Google Scholar] [CrossRef]
  29. Kyung, S.; Rahmati, M.; Kang, J.; Lee, K.; Lee, H.; Yon, D.K. Global and Regional Burden of Vaccine-Associated Erythema Multiforme and their Related Vaccines, 1967-2023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database. Med. Princ. Pract. 2024, 4, 1–18. [Google Scholar] [CrossRef]
  30. Miyazato, Y.; Terada, M.; Ujiie, M.; Lee, K.; Lee, H.; Yon, D.K. A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan. J. Travel. Med. 2023, 30, taac070. [Google Scholar] [CrossRef]
  31. Wong, N.X.; Buttery, J.; McMinn, A.; Azhar, Z.; Crawford, N.W. Safety of the Polish BCG-10 Vaccine During a Period of BCG Vaccine Shortage: An Australian Experience. Pediatr. Infect. Dis. J. 2020, 39, e66–e68. [Google Scholar] [CrossRef] [PubMed]
  32. Groom, A.V.; Cheek, J.E.; Bryan, R.T. Effect of a national vaccine shortage on vaccine coverage for American Indian/Alaska Native children. Am. J. Public Health 2006, 96, 697–701. [Google Scholar] [CrossRef] [PubMed]
  33. Flavia, A.; Fred, B.; Eleanor, T. Gaps in vaccine management practices during vaccination outreach sessions in rural settings in southwestern Uganda. BMC Infect. Dis. 2023, 23, 758. [Google Scholar] [CrossRef] [PubMed]
  34. Feinmann, J. Vaccine shortages worsen the deadliest cholera outbreaks in years. BMJ 2024, 385, q1228. [Google Scholar] [CrossRef] [PubMed]
  35. Miranda-García, M.A.; Hoffelner, M.; Stoll, H.; Ruhaltinger, D.; Cichutek, K.; Siedler, A.; Bekeredjian-Ding, I. A 5-year look-back at the notification and management of vaccine supply shortages in Germany. Euro. Surveill. 2022, 27, 2100167. [Google Scholar] [CrossRef]
  36. Kempe, A.; Daley, M.F.; Stokley, S.; Crane, L.A.; Beaty, B.L.; Barrow, J.; Babbel, C.; Dickinson, L.M.; Steiner, J.F.; Berman, S.; et al. Impact of a severe influenza vaccine shortage on primary care practice. Am. J. Prev. Med. 2007, 33, 486–491. [Google Scholar] [CrossRef]
  37. Glatman-Freedman, A.; Cohen, M.L.; Nichols, K.A.; Porges, R.F.; Saludes, I.R.; Steffens, K.; Rodwin, V.G.; Britt, D.W. Factors affecting the introduction of new vaccines to poor nations: A comparative study of the Haemophilus influenzae type B and hepatitis B vaccines. PLoS ONE 2010, 5, e13802. [Google Scholar] [CrossRef]
  38. Gaitán-Rossi, P.; Mendez-Rosenzweig, M.; García-Alberto, E.; Vilar-Compte, M. Barriers to COVID-19 vaccination among older adults in Mexico City. Int. J. Equity. Health 2022, 21, 85. [Google Scholar] [CrossRef]
  39. Jammeh, A.; Muhoozi, M.; Kulane, A.; Kajungu, D. Comparing full immunisation status of children (0-23 months) between slums of Kampala City and the rural setting of Iganga District in Uganda: A cross-sectional study. BMC Health Serv. Res. 2023, 23, 856. [Google Scholar] [CrossRef]
  40. Vasudevan, L.; Baumgartner, J.N.; Moses, S.; Ngadaya, E.; Mfinanga, S.G.; Ostermann, J. Parental concerns and uptake of childhood vaccines in rural Tanzania—A mixed methods study. BMC Public Health 2020, 20, 1573. [Google Scholar] [CrossRef]
  41. Babalola, S. Maternal reasons for non-immunisation and partial immunisation in northern Nigeria. J. Paediatr. Child Health 2011, 47, 276–281. [Google Scholar] [CrossRef] [PubMed]
  42. Abdulraheem, I.S.; Onajole, A.T.; Jimoh, A.A.G.; Oladipo, A.R. Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children. J. Public Health Epidemiol. 2011, 3, 194–203. [Google Scholar]
  43. Abebe, A.M.; Mengistu, T.; Mekuria, A.D. Measles case, immunization coverage and its determinant factors among 12-23 month children, in Bassona Worena Woreda, Amhara Region, Ethiopia, 2018. BMC Res. Notes. 2019, 12, 71. [Google Scholar] [CrossRef] [PubMed]
  44. Adamu, A.A.; Uthman, O.A.; Gadanya, M.A.; Cooper, S.; Wiysonge, C.S. Using the theoretical domains framework to explore reasons for missed opportunities for vaccination among children in Kano, Nigeria: A qualitative study in the pre-implementation phase of a collaborative quality improvement project. Expert Rev. Vaccines. 2019, 18, 847–857. [Google Scholar] [CrossRef]
  45. Atwiine, B.; Rukundo, A.; Elias, B.; MacDonald, N.E. Reasons for non-timely completion of the routine infant immunization schedule by children in rural South West Uganda. Can. J. Public Health 2016, 106, e564. [Google Scholar] [CrossRef]
  46. Babirye, J.N.; Rutebemberwa, E.; Kiguli, J.; Wamani, H.; Nuwaha, F.; Engebretsen, I.M. More support for mothers: A qualitative study on factors affecting immunisation behaviour in Kampala, Uganda. BMC Public Health 2011, 11, 723. [Google Scholar] [CrossRef]
  47. Babirye, J.N.; Engebretsen, I.M.; Rutebemberwa, E.; Kiguli, J.; Nuwaha, F. Urban settings do not ensure access to services: Findings from the immunisation programme in Kampala Uganda. BMC Health Serv. Res. 2014, 14, 111. [Google Scholar] [CrossRef]
  48. Cockcroft, A.; Usman, M.U.; Nyamucherera, O.F.; Emori , H.; Duke, B.; Umar, N.A.; Andersson, N. Why children are not vaccinated against measles: A cross-sectional study in two Nigerian States. Arch Public Health 2014, 72, 48. [Google Scholar] [CrossRef]
  49. Holte, J.H.; Mæstad, O.; Jani, J.V. The decision to vaccinate a child: An economic perspective from southern Malawi. Soc. Sci. Med. 2012, 75, 384–391. [Google Scholar] [CrossRef]
  50. Itimi, K.; Dienye, P.O.; Ordinioha, B. Community participation and childhood immunization coverage: A comparative study of rural and urban communities of Bayelsa State, south-south Nigeria. Niger. Med. J. 2012, 53, 21–25. [Google Scholar] [CrossRef]
  51. Kagone, M.; Ye, M.; Nebie, E.; Sié, A.; Müller, O.; Beiersmann, C. Community perception regarding childhood vaccinations and its implications for effectiveness: A qualitative study in rural Burkina Faso. BMC Public Health 2018, 18, 324. [Google Scholar] [CrossRef] [PubMed]
  52. Kwedi Nolna, S.; Bonono, C.R.; Nsangou Moncher, M.; Bindé, T.; Nolna, D.; Ongolo Zogo, P. Factors influencing the performance of routine immunization in urban areas: A comparative case study of two cities in Cameroon: Douala and Yaoundé. Vaccine 2018, 36, 7549–7555. [Google Scholar] [CrossRef] [PubMed]
  53. LaMontagne, D.S.; Barge, S.; Le, N.T.; Mugisha, E.; Penny, M.E.; Gandhi, S.; Janmohamed, A.; Kumakech, E.; Mosqueira, N.R.; Nguyen, N.Q.; et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ. 2011, 89, 821–830B. [Google Scholar] [CrossRef]
  54. Mbabazi, W.; Lako, A.K.; Ngemera, D.; Laku, R.; Yehia, M.; Nshakira, N. Maiden immunization coverage survey in the republic of South Sudan: A cross-sectional study providing baselines for future performance measurement. Pan. Afr. Med. J. 2013, 16, 110. [Google Scholar] [CrossRef]
  55. Mekonnen, A.G.; Bayleyegn, A.D.; Ayele, E.T. Immunization coverage of 12-23 months old children and its associated factors in Minjar-Shenkora district, Ethiopia: A community-based study. BMC Pediatr. 2019, 19, 198. [Google Scholar] [CrossRef]
  56. Meyer, S.A.; Kambou, J.L.; Cohn, A.; Goodson, J.L.; Flannery, B.; Medah, I.; Messonnier, N.; Novak, R.; Diomande, F.; Djingarey, M.H.; et al. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso–implications for introduction of PsA-TT into the Expanded Programme on Immunization. Vaccine 2015, 3, 1492–1498. [Google Scholar] [CrossRef]
  57. Michael, C.A.; Ashenafi, S.; Ogbuanu, I.U.; Ohuabunwo, C.; Sule, A.; Corkum, M.; Mackay, S.; Storms, A.D.; Achari, P.; Biya, O.; et al. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign–Katsina State, Nigeria. J. Infect. Dis. 2014, 210, S131–S135. [Google Scholar] [CrossRef]
  58. Michael, C.A.; Ogbuanu, I.U.; Storms, A.D.; Ohuabunwo, C.J.; Corkum, M.; Ashenafi, S.; Achari, P.; Biya, O.; Nguku, P.; Mahoney, F.; et al. An assessment of the reasons for oral poliovirus vaccine refusals in Northern Nigeria. J. Infect. Dis. 2014, 210, S125–S130. [Google Scholar] [CrossRef]
  59. Msyamboza, K.P.; Mwagomba, B.M.; Valle, M.; Chiumia, H.; Phiri, T. Implementation of a human papillomavirus vaccination demonstration project in Malawi: Successes and challenges. BMC Public Health 2017, 17, 599. [Google Scholar] [CrossRef]
  60. Murele, B.; Vaz, R.; Gasasira, A.; Mkanda, P.; Erbeto, T.; Okeibunor, J. Vaccine perception among acceptors and non-acceptors in Sokoto State, Nigeria. Vaccine 2014, 32, 3323–3327. [Google Scholar] [CrossRef]
  61. Nabirye, J.; Okwi, L.A.; Nuwematsiko, R.; Kiwanuka, G.; Muneza, F.; Kamya, C.; Babirye, J.N. Health system factors influencing uptake of Human Papilloma Virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda. BMC Public Health 2020, 20, 171. [Google Scholar] [CrossRef]
  62. Nguefack Dongmo, F.; Tassadong, C.; Dongmo, R.; Tatah, S.; Fodoung, W.D.S.; Chiabi, A.; Kago, I.; Kobela, M. Factors influencing routine vaccination of children of mothers live-stock retailers in the markets of Yaoundé. World J. Vaccin. 2016, 6, 23–33. [Google Scholar] [CrossRef]
  63. Njeru, I.; Ajack, Y.; Muitherero, C.; Onyango, D.; Musyoka, J.; Onuekusi, I.; Kioko, J.; Muraguri, N.; Davis, R. Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? a cross-sectional study. Pan. Afr. Med. J. 2016, 24, 120. [Google Scholar] [CrossRef]
  64. Nsubuga, F.; Kabwama, S.N.; Ampeire, I.; Luzze, H.; Gerald, P.; Bulage, L.; Toliva, O.B. Comparing static and outreach immunization strategies and associated factors in Uganda, Nov-Dec 2016. Pan. Afr. Med. J. 2019, 32, 123. [Google Scholar] [CrossRef]
  65. Okenwa, U.J.; Dairo, M.D.; Uba, B.; Ajumobi, O. Maternal reasons for non-receipt of valid Hepatitis B birth dose among mother-infant pairs attending routine immunization clinics, South-east, Nigeria. Vaccine 2019, 37, 6894–6899. [Google Scholar] [CrossRef]
  66. Oladokun, R.E.; Adedokun, B.O.; Lawoyin, T.O. Children not receiving adequate immunization in Ibadan, Nigeria: What reasons and beliefs do their mothers have? Niger. J. Clin. Pract. 2010, 13, 173–178. [Google Scholar]
  67. Atkinson, K.; Ntacyabukura, B.; Hawken, S.; El-Khatib, Z.; Laflamme, L.; Wilson, K. Parent and family characteristics associated with reported pediatric influenza vaccination in a sample of Canadian digital vaccination platform users. An exploratory, cross-sectional study in the 2018-2019 influenza season. Hum. Vaccin. Immunother. 2024, 20, 2378580. [Google Scholar] [CrossRef]
  68. Kim, K.; Parekh De Campos, A.; Choi, S. A Vax4HPV Mobile Application for Parents of Human Papillomavirus Vaccine-Eligible Children: Iterative Formative Assessments. Comput. Inform. Nurs. 2022, 40, 455–465. [Google Scholar] [CrossRef]
  69. Shegog, R.; Savas, L.S.; Healy, C.M.; Frost, E.L.; Coan, S.P.; Gabay, E.K.; Preston, S.M.; Spinner, S.W.; Wilbur, M.; Becker, E.; et al. AVPCancerFree: Impact of a digital behavior change intervention on parental HPV vaccine -related perceptions and behaviors. Hum. Vaccin. Immunother. 2022, 18, 2087430. [Google Scholar] [CrossRef]
  70. Ortiz, R.R.; Shafer, A.; Cates, J.; Coyne-Beasley, T. Development and Evaluation of a Social Media Health Intervention to Improve Adolescents’ Knowledge About and Vaccination Against the Human Papillomavirus. Glob. Pediatr. Health. 2018, 5, 2333794X18777918. [Google Scholar] [CrossRef]
  71. Buller, D.B.; Pagoto, S.; Henry, K.; Berteletti, J.; Walkosz, B.J.; Bibeau, J.; Baker, K.; Hillhouse, J.; Arroyo, K.M. Human Papillomavirus Vaccination and Social Media: Results in a Trial With Mothers of Daughters Aged 14-17. Front. Digit. Health 2021, 3, 683034. [Google Scholar] [CrossRef] [PubMed]
  72. Chodick, G.; Teper, G.R.; Levi, S.; Kopel, H.; Kleinbort, A.; Khen, E.; Schejter, E.; Shalev, V.; Stein, M.; Lewis, N. The impact of a Facebook campaign among mothers on HPV vaccine uptake among their daughters: A randomized field study. Gynecol. Oncol. 2021, 160, 106–111. [Google Scholar] [CrossRef] [PubMed]
  73. Occa, A.; Stahl, H.M.; Julien-Bell, S. Helping Children to Participate in Human Papillomavirus-Related Discussions: Mixed Methods Study of Multimedia Messages. JMIR Form Res. 2022, 6, e28676. [Google Scholar] [CrossRef]
  74. Chen, A.C.; Kim, W.S.; Todd, M.; Larkey, L. A Digital Storytelling Intervention for Vietnamese American Mothers to Promote Their Children’s HPV Vaccination. Cancer Prev. Res. 2022, 15, 465–472. [Google Scholar] [CrossRef]
  75. Woodall, W.G.; Zimet, G.; Kong, A.; Buller, D.; Reither, J.; Chilton, L.; Myers, V.; Starling, R. Vacteens.org: A Mobile Web app to Improve HPV Vaccine Uptake. Front. Digit. Health 2021, 3, 693688. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ma, S.; Bi, Q.; Liu, L.; Thapa, R.; Li, W.; Liu, B.; Xu, C.; Sun, C. Special Issue: “Vaccination and Global Health”. Vaccines 2024, 12, 1223. https://doi.org/10.3390/vaccines12111223

AMA Style

Ma S, Bi Q, Liu L, Thapa R, Li W, Liu B, Xu C, Sun C. Special Issue: “Vaccination and Global Health”. Vaccines. 2024; 12(11):1223. https://doi.org/10.3390/vaccines12111223

Chicago/Turabian Style

Ma, Shaodi, Qian Bi, Li Liu, Roshan Thapa, Wenle Li, Baocheng Liu, Chuanhui Xu, and Chenyu Sun. 2024. "Special Issue: “Vaccination and Global Health”" Vaccines 12, no. 11: 1223. https://doi.org/10.3390/vaccines12111223

APA Style

Ma, S., Bi, Q., Liu, L., Thapa, R., Li, W., Liu, B., Xu, C., & Sun, C. (2024). Special Issue: “Vaccination and Global Health”. Vaccines, 12(11), 1223. https://doi.org/10.3390/vaccines12111223

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop